Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19)

References

• Fathizadeh H, Maroufi P, Momen-Heravi M, et al. Protection and disinfection policies against SARS-CoV-2 (COVID-19). Infez Med. 2020;28(2):185–191.32275260
   PubMedGoogle Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa200101731978945
   PubMed Web of Science ®Google Scholar
• Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473. doi:10.1016/S0140-6736(20)30185-931986257
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. doi:10.1016/S0140-6736(20)30251-832007145
   PubMed Web of Science ®Google Scholar
• Lai -C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi:10.1016/j.ijantimicag.2020.10592432081636
   PubMed Web of Science ®Google Scholar
• Ozma MA, Maroufi P, Khodadadi E, et al. Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (Covid-19) during the outbreak period. Infez Med. 2020;28(2).
   PubMedGoogle Scholar
• Chang D, Lin M, Wei L, et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA. 2020;323(11):1092. doi:10.1001/jama.2020.1623
   PubMed Web of Science ®Google Scholar
• Guicciardi M, Gores GJ. Apoptosis: a mechanism of acute and chronic liver injury. Gut. 2005;54(7):1024–1033. doi:10.1136/gut.2004.05385015951554
   PubMed Web of Science ®Google Scholar
• Tang LS, Covert E, Wilson E, Kottilil S. Chronic hepatitis B infection: a review. JAMA. 2018;319(17):1802–1813. doi:10.1001/jama.2018.379529715359
   PubMed Web of Science ®Google Scholar
• Tseng T-C, Liu C-J, Chang CT, et al. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis. J Hepatol. 2020;72(6):1105–1111. doi:10.1016/j.jhep.2020.01.01232006586
   PubMed Web of Science ®Google Scholar
• Nguyen L, Nguyen M. Systematic review: asian patients with chronic hepatitis C infection. Aliment Pharmacol Ther. 2013;37(10):921–936. doi:10.1111/apt.1230023557103
   PubMed Web of Science ®Google Scholar
• Chau TN, Lee KC, Yao H, et al. SARS‐associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004;39(2):302–310. doi:10.1002/hep.2011114767982
   PubMed Web of Science ®Google Scholar
• Lee JY, Kim Y-J, Chung EH, et al. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect Dis. 2017;17(1):498. doi:10.1186/s12879-017-2576-528709419
   PubMed Web of Science ®Google Scholar
• Li L, Li S, Xu M, et al. The level of plasma C-reactive protein is closely related to the liver injury in patients with COVID-19. medRxiv. 2020.
   Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Supplement_2):S27–S72.17278083
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-732007143
   PubMed Web of Science ®Google Scholar
• Chai X, Hu L, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv. 2020.
   Google Scholar
• Johnston DE. Special considerations in interpreting liver function tests. Am Fam Physician. 1999;59(8):2223.10221307
   PubMed Web of Science ®Google Scholar
• Yap CY, Aw TC. Liver function tests (LFTs). Proc Singapore Healthc. 2010;19(1):80–82. doi:10.1177/201010581001900113
   Google Scholar
• Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem. 2000;46(12):2050–2068. doi:10.1093/clinchem/46.12.205011106350
   PubMed Web of Science ®Google Scholar
• Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020;80(4):388–393. doi:10.1016/j.jinf.2020.02.01632112884
   PubMed Web of Science ®Google Scholar
• Ju C-R, Lian Q-Y, Zhang J-H, et al. Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients. Chronic Dis Transl Med. 2020. doi:10.1016/j.cdtm.2020.02.003
   PubMedGoogle Scholar
• Mori S, Watanabe W, Shigeta S. A colorimetric LDH assay for the titration of infectivity and the evaluation of anti-viral activity against ortho-and paramyxoviruses. Tohoku J Exp Med. 1995;177(4):315–325. doi:10.1620/tjem.177.3158928191
   PubMed Web of Science ®Google Scholar
• Watanabe W, Sudo K, Asawa S, Konno K, Yokota T, Shigeta S. Use of lactate dehydrogenase to evaluate the anti-viral activity against influenza A virus. J Virol Methods. 1995;51(2–3):185–191. doi:10.1016/0166-0934(94)00103-N7738138
   PubMed Web of Science ®Google Scholar
• Uchide N, Ohyama K, Bessho T, Toyoda H. Lactate dehydrogenase leakage as a marker for apoptotic cell degradation induced by influenza virus infection in human fetal membrane cells. Intervirology. 2009;52(3):164–173. doi:10.1159/00022464419521105
   PubMed Web of Science ®Google Scholar
• Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol. 2005;288(5):H2031–H2041. doi:10.1152/ajpheart.01058.200415653761
   PubMed Web of Science ®Google Scholar
• Wu W, Shi D, Fang D, et al. A new perspective on C-reactive protein in H7N9 infections. Int J Infect Dis. 2016;44:31–36. doi:10.1016/j.ijid.2016.01.00926809124
   PubMed Web of Science ®Google Scholar
• Vasileva D, Badawi A. C-reactive protein as a biomarker of severe H1N1 influenza. Inflamm Res. 2019;68(1):39–46. doi:10.1007/s00011-018-1188-x30288556
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061. doi:10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhou L, Yang Y, Peng W, Wang W, Chen X. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. Lancet Res Med. 2020;8(3):e11–e12. doi:10.1016/S2213-2600(20)30071-0
   PubMed Web of Science ®Google Scholar
• Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. 2020.
   Google Scholar
• Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. BioRxiv. 2020.
   Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X32085846
   PubMed Web of Science ®Google Scholar
• Zhang C, Shi L, Wang F-S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428–430. doi:10.1016/S2468-1253(20)30057-132145190
   PubMed Web of Science ®Google Scholar